Skip to main content
OpenTrials

Clinical trial condition

Ovarian Neoplasms

Explore clinical trials studying Ovarian Neoplasms. Study availability and eligibility vary by location and protocol.

194 public trials 42 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Neoplasms trial results

Recruiting

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

NCT07318558

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • Mount Sinai Cancer Center ( Site 0029) Miami Beach, Florida, United States
  • Orlando Health Winnie Palmer Hospital for Women and Babies ( Site 0085) Orlando, Florida, United States
  • Winship Cancer Institute of Emory University ( Site 0037) Atlanta, Georgia, United States
  • Illinois Cancer Specialists (ICS) ( Site 8009) Arlington Heights, Illinois, United States
View all 135 locations
View Trial Details
Recruiting

Centralization and Oncologic Outcomes in Ovarian Cancer

NCT07075939

Conditions
Adnexal Diseases, Advanced Ovarian Cancer, COVID-19, +30 more
Locations
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Razzini Carpi Carpi, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale di Mirandola Mirandola, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Pavullo nel Frignano Pavullo nel Frignano, Modena, Italy
  • Azienda Unità - Sanitaria locale di Modena - Ospedale Civile Sassuolo Sassuolo, Modena, Italy
View Trial Details
Recruiting

A Study to Investigate Mocertatug Rezetecan Compared With Standard of Care in Participants With Platinum-resistant Ovarian Cancer (BEHOLD-Ovarian01)

NCT07286266

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +12 more
Locations
  • GSK Investigational Site Randwick, New South Wales, Australia
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Montreal, Quebec, Canada
  • GSK Investigational Site Hyōgo, Japan
View Trial Details
Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

NCT07213791

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +39 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
  • Moffitt Tampa, Florida, United States
View all 30 locations
View Trial Details
Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

NCT04389632

Conditions
Adenocarcinoma Of Esophagus, Adnexal Diseases, Bronchial Neoplasms, +52 more
Locations
  • Alaska Oncology and Hematology Anchorage, Alaska, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
View all 158 locations
View Trial Details
Recruiting

A Study of DM002 in Patients With Advanced Solid Tumors

NCT06751329

Conditions
Adnexal Diseases, Colonic Diseases, Colorectal Neoplasms, +33 more
Locations
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
  • The University of Texas, MD Anderson Cancer Center Houston, Texas, United States
  • Scientia Clinical Research Randwick, New South Wales, Australia
  • Cancer Care Wollongong Wollongong, New South Wales, Australia
View Trial Details
Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

NCT04895709

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +56 more
Locations
  • Community Cancer Institute Clovis, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • University of Iowa Iowa City, Iowa, United States
View all 47 locations
View Trial Details
Recruiting

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

NCT04641247

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +16 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Encinitas, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Whittier, California, United States
View all 25 locations
View Trial Details
Recruiting

A Study of LY4170156 in Participants With Selected Advanced Solid Tumors

NCT06400472

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +42 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • NYU Langone Health - Long Island Mineola, New York, United States
View all 23 locations
View Trial Details

Related conditions